Liposclerosing myxofibrous tumor is a very rare benign fibro-osseous lesion. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] It is thought to be associated with fibrous dysplasia because of its clinical, histological and radiological features. This lesion, which is often located in the proximal femur, rarely shows malignant transformation. In this case report, we aim to present a very rare liposclerosing myxofibrous tumor case, which was treated surgically, in light of the literature review.
CASE REPORT
A 67-year-old male patient admitted to our clinic with a complaint of increasing pain by walking for six months in the right hip and thigh. Right hip joint movements were normal at the physical examination. His complaints were increasing particularly with activity. The patient, who had a medical history of surgery due to prostate cancer 15 years before, was under the follow of oncology outpatient clinics. His laboratory findings were normal and prostate specific antigen was 3.03 ng/mL. In the radiological examination; a proximal femoral lesion, starting from right femoral neck and extending to 4 cm below the minor trochanter, separated by a thin sclerotic line from the surrounding tissue, was detected (Figure 1 
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examination; a lobulated, 7x3 cm lesion starting from right femoral neck and extending to femoral diaphysis, separated by a thin sclerotic line from the surrounding tissue, was detected. It was hyperintense on T 2 -weighted and hypointense on T 1 -weighted images. The lesion had contrast enchancement in post-contrast series and there were thin septations inside the lesion (Figure 2 ). At the positron emission tomography-computed tomography examination; increased activity in the prostate, seminal vesicles and right femoral neck was detected. Surgical treatment was planned because of patient's pain complaints and suspected possible bone metastasis.
Firstly, a closed bone biopsy under flouroscopy was performed because lesion was atypical in shape and there was only one bone lesion. On the microscopic examination of the lesion; mixofibrous tissue similar to scattered xanthomatous communities and bone trabeculae similar to fibrous dysplasia were observed. Immunohistochemically, immunoreactivity with smooth muscle actin in the spindle cells of stroma was observed. In light of these findings, the diagnosis of the lesion was reported as liposclerosing myxofibrous tumor (Figures 3, 4 ).
An intralesional operation was planned. Under general anesthesia, the surgery was initiated with right femur lateral incision on the traction table. After reaching the bone, an oval window was opened. After the entire curettage of the lesion, the walls of the lesion were expanded with the help of high-speed burr. The walls of the lesion were cauterized with 120 W argon plasma coagulatin till all lesion walls turned to black in color and bone grafting with 90 mL cancellous allograft was performed. Because of the pathologic fracture risk at the load-bearing region, fixation with a 95-degree dynamic condylar screw (DCS)-plate system was performed. In the pathological examination; liposclerosing myxofibrous tumor was confirmed. Patient was mobilized with crutches on first postoperative day, and he walked by fourth week with full loading. Patient was asymptomatic at the 16 th month control and recurrence was not detected ( Figure 5) . A written informed consent was obtained from the patient.
DISCUSSION
Liposclerosing myxofibrous tumor was first described by Ragsdale in 1986 . [1, 5, 11] It has a complicated structure, which histopathologically includes myxoid areas, osteoclastic activity, bone trabeculae similar to fibrous dysplasia, fat necrosis, ischemic ossification and rarely cartilage components. [1] [2] [3] 5, 11] The average age of disease occurrence is 40 years. The frequency of males and females is equal. Although a large portion of the proximal femur is affected, other localizations have also been reported, albeit rarely. [11] Radiologically, it is a well-circumscribed lesion surrounded by sclerosis, which shows calcification occasionally. [3, 4, 9] However, biopsy is required due to being very rare. In the differential diagnosis of our case, due to patient's being 67 years old and having a history of prostate carcinoma, metastatic lesion came to mind. However, failure of definitive diagnosis with radiological assessment, even it is a metastasis, percutaneous Jamshidi needle biopsy was performed since the lesion was solitary. Definitive treatment was planned when the biopsy confirmed the diagnosis.
Liposclerosing myxofibrous tumor has been reported to be associated with fibrous dysplasia because of its radiological and histopathological features. They are intramedullary well-limited lesions just as classic fibrous dysplasia. [12] Indeed, Matsuba et al. [8] detected Gs alpha mutation at Arg201 codon in two cases of liposclerosing myxofibrous tumor. These mutations have also been identified in patients with McCune-Albright syndrome, and monostotic and polyostotic fibrous dysplasia. [6, 8] In a study presented by Datillo et al. [13] in 2012, a total of 33 liposclerosing myxofibrous tumor cases were evaluated. Of the 33 cases, histopathologic materials of 18 could be reached. Histopathologically, 12 patients had degenerative form of fibrous dysplasia and three patients had degenerative form of intraosseous lipoma. For this reason, the authors could not establish a diagnosis of liposclerosing myxofibrous tumor. However, the current literature indicates that the diagnosis of liposclerous myxofibroscopic tumor is still considered as a separate lesion. [14] [15] [16] [17] We think that due to the presence of myxoid structures composed of fibrous tissue separated by adipose tissue, our case should not be regarded as only intraosseous lipoma or fibrous dysplasia (Figure 3) . Thus, we believe that liposclerosing myxofibrous tumor should be managed as a separate entity, as indicated in current sources.
Curettage, bone grafting and cementing by intralesional approach are sufficient for treatment due to its being a benign tumor. Yet, malignant transformation has also been reported, albeit very rarely. [2, 5, 11] In our case, we also applied curettage and grafting with allograft and fixation with 95-degree DCS-plate system. [6] In the surgical treatment, aggressive curettage of the lesion, and use of high-speed burr and adjuvant therapy are important. We routinely prefer to use argon beam cautery as adjuvant therapy in patients with tumors. In case of failure to pay sufficient attention in these steps of treatment, the rate of recurrence increases. [14] We used a 95-degree DCS-plate fixation in order to prevent the risk of fracture at the load carrying area where we opened a bone window. Recurrence was not detected at the 16 th month control.
Malignant transformations such as fibrosarcoma, malignant fibrous histiocytoma and telangiectatic osteosarcoma have been reported. [2, 5, 11] In the literature, a malignant transformation rate of 10% has been reported. [1, 9] In conclusion, liposclerosing myxofibrous tumor should come to mind in the differential diagnosis of heterogeneous, lytic lesions surrounded by sclerosis of proximal femur. Like all other bone tumors, physical examination and evaluation with imaging methods should be performed. If there is any doubt in the diagnosis of the disease, it is very important to implement biopsy before permanent treatment. Because of the risk of malignancy and fracture, surgery should be the preferred treatment. Case series with larger sample size are needed to clarify the relationship with fibrous dysplasia lesions and the progression of the disease.
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